Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and potential usefulness of liposomal curcumin in patients with refractory or relapsed multiple myeloma. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal Curcumin (curcumin liposomal formulation)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Multiple Myeloma Refractory, Multiple Myeloma in Relapse | Phase 1 | Status: NOT_YET_RECRUITING